Kornberg A - Search Results

1

Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients.

Kornberg A, Küpper B, Wilberg J, Tannapfel A, Thrum K, Bärthel E, Hommann M, Settmacher U. Kornberg A, et al. Transpl Infect Dis. 2007 Dec;9(4):295-301. doi: 10.1111/j.1399-3062.2007.00228.x. Epub 2007 May 19. Transpl Infect Dis. 2007. PMID: 17511824 Clinical Trial.

2

Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction.

Kornberg A, Küpper B, Hommann M, Scheele J. Kornberg A, et al. Int Immunopharmacol. 2005 Jan;5(1):141-6. doi: 10.1016/j.intimp.2004.09.018. Int Immunopharmacol. 2005. PMID: 15589474 Clinical Trial.

3

Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology.

Kornberg A, Küpper B, Tannapfel A, Thrum K, Bärthel E, Settmacher U. Kornberg A, et al. Liver Int. 2006 Sep;26(7):811-6. doi: 10.1111/j.1478-3231.2006.01301.x. Liver Int. 2006. PMID: 16911463

4

Antiviral maintenance treatment with interferon and ribavirin for recurrent hepatitis C after liver transplantation: pilot study.

Kornberg A, Küpper B, Tannapfel A, Bärthel E, Thrum K, Settmacher U. Kornberg A, et al. J Gastroenterol Hepatol. 2007 Dec;22(12):2135-42. doi: 10.1111/j.1440-1746.2006.04516.x. J Gastroenterol Hepatol. 2007. PMID: 18031371 Clinical Trial.

5

Sustained clearance of serum hepatitis C virus-RNA independently predicts long-term survival in liver transplant patients with recurrent hepatitis C.

Kornberg A, Küpper B, Tannapfel A, Thrum K, Bärthel E, Habrecht O, Settmacher U. Kornberg A, et al. Transplantation. 2008 Aug 15;86(3):469-73. doi: 10.1097/TP.0b013e31817c0e20. Transplantation. 2008. PMID: 18698252 Clinical Trial.

6

Combined en-bloc liver-pancreas transplantation in patients with liver cirrhosis and insulin-dependent type 2 diabetes mellitus.

Kornberg A, Küpper B, Bärthel E, Tannapfel A, Müller UA, Thrum K, Kloos C, Wolf G. Kornberg A, et al. Transplantation. 2009 Feb 27;87(4):542-5. doi: 10.1097/TP.0b013e3181949cce. Transplantation. 2009. PMID: 19307791

7

Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients.

Kornberg A, Hommann M, Tannapfel A, Wagner T, Grube T, Schotte U, Voigt R, Scheele J. Kornberg A, et al. Am J Transplant. 2001 Nov;1(4):350-5. doi: 10.1034/j.1600-6143.2001.10410.x. Am J Transplant. 2001. PMID: 12099379 Free article.

8

Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology.

Kornberg A, Hommann M, Tannapfel A, Grube T, Schotte U, Scheele J. Kornberg A, et al. Transplant Proc. 2002 Sep;34(6):2259-60. doi: 10.1016/s0041-1345(02)03226-8. Transplant Proc. 2002. PMID: 12270389 Clinical Trial. No abstract available.

9

Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.

Kornberg A, Küpper B, Tannapfel A, Hommann M, Scheele J. Kornberg A, et al. Int Immunopharmacol. 2005 Jan;5(1):107-15. doi: 10.1016/j.intimp.2004.09.010. Int Immunopharmacol. 2005. PMID: 15589468 Clinical Trial.

10

Prevention of early loss of bone mineral density after liver transplantation by prostaglandin E1.

Hommann M, Kämmerer D, Lehmann G, Kornberg A, Küpper B, Daffner W, Wolf G, Settmacher U. Hommann M, et al. Among authors: kornberg a. Transplant Proc. 2007 Mar;39(2):540-3. doi: 10.1016/j.transproceed.2006.12.016. Transplant Proc. 2007. PMID: 17362777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters